论文部分内容阅读
中国和美国用ＤＲ－ ７０ＴＭ （肿瘤标志物）免疫试剂在检测３９３ 例健康对照及２０３ 例肺癌中的实用性的一个多中心研究，同时也进行了不同疾病和血液收集方法对ＤＲ－ ７０ＴＭ 试验产生干扰的调查。研究发现良性和非癌性疾病能引起ＤＲ－ ７０ＴＭ 水平的提高
A multicenter study of the utility of the DR-70TM (tumor marker) immunoassay in 393 healthy controls and 203 lung cancers in China and the United States, as well as different disease and blood collection methods for DR-70TM trials Interference investigations. Study found that benign and non-cancerous diseases can cause increased levels of DR-70TM